<![CDATA[Era7 Bioinformatics - 454]]> <![CDATA[Era7 Bioinformatics - 454]]> http://era7bioinformatics.com/assets/logo_asnc.jpg http://era7bioinformatics.com/web/page.cfm?id=316 <![CDATA[]]> Disadvantages:

]]>
<![CDATA[Read length]]> Its main advantage was the length of the reads

]]>
<![CDATA[454 GS Junior.]]> A personal Sequencer.

]]>
<![CDATA[454 FLX+ ]]> <![CDATA[]]> 454 platforms :

]]>
<![CDATA[Amplicons]]> <![CDATA[De novo RNA-seq]]> <![CDATA[Bacterial Genomics]]> <![CDATA[16S Metagenomics]]> <![CDATA[]]> As this was the first technology introduced in the market for NGS, in Era7 Bionformatics we have a lot of experience analyzing data from 454 machines:

]]>
<![CDATA[Not uniform coverage]]> <![CDATA[Frequent errors in homopolymers ]]> <![CDATA[High price compared with yielding]]> <![CDATA[]]> 454 was the first NGS platform that appeared in the market.

 

Advantages:

]]>